Recruiting Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) NCT04315324 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Kingman Regional Medical Center — Kingman, Arizona, United States Arkansas Children's Hospital — Little Rock, Arkansas, United States PCR Oncology — Arroyo Grande, California, United States View all 163 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies NCT04681105 Conditions Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
Active, Not Recruiting Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia NCT03504644 Conditions Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +29 more Locations Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States Alaska Breast Care and Surgery LLC — Anchorage, Alaska, United States Alaska Oncology and Hematology LLC — Anchorage, Alaska, United States View all 170 locations View more locations Show fewer locations Loading locations... View Trial Details
